keyword
https://read.qxmd.com/read/38739808/her2-sirna-facilitated-gene-silencing-coupled-with-doxorubicin-delivery-a-dual-responsive-nanoplatform-abrogates-breast-cancer
#1
JOURNAL ARTICLE
Archana M G, Anusree K S, Unnikrishnan B S, Reshma P L, Syama H P, Sreekutty J, Manu M Joseph, Sreelekha T T
The present study investigated the concurrent delivery of antineoplastic drug, doxorubicin, and HER2 siRNA through a targeted theranostic metallic gold nanoparticle designed using polysaccharide, PSP001. The as-synthesized HsiRNA@PGD NPs were characterized in terms of structural, functional, physicochemical, and biological properties. HsiRNA@PGD NPs exposed adequate hydrodynamic size, considerable ζ potential, and excellent drug/siRNA loading and encapsulation efficiency. Meticulous exploration of the biocompatible dual-targeted nanoconjugate exhibited an appealing biocompatibility and pH-sensitive cargo release kinetics, indicating its safety for use in clinics...
May 13, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38739704/improving-outcomes-in-pediatric-ntrk-gene-fusion-positive-solid-tumors-importance-of-genomic-testing-and-targeted-therapy-with-the-trk-inhibitor-larotrectinib
#2
JOURNAL ARTICLE
Theodore W Laetsch
No abstract text is available yet for this article.
May 2024: Clinical Advances in Hematology & Oncology: H&O
https://read.qxmd.com/read/38739691/new-insight-in-treating-autoimmune-diseases-by-targeting-autophagy
#3
REVIEW
Jiao Lyu, Hongqian Zhang, Chaoyang Wang, Mingyu Pan
Autophagy is a highly conserved biological process in eukaryotes, which degrades cellular misfolded proteins, damaged organelles and invasive pathogens in the lysosome-dependent manner. Autoimmune diseases caused by genetic elements, environments and aberrant immune responses severely impact patients' living quality and even threaten life. Recently, numerous studies have reported autophagy can regulate immune responses, and play an important role in autoimmune diseases. In this review, we summarised the features of autophagy and autophagy-related genes, enumerated some autophagy-related genes involved in autoimmune diseases, and further overviewed how to treat autoimmune diseases through targeting autophagy...
December 2024: Autoimmunity
https://read.qxmd.com/read/38739634/identification-of-potential-biomarkers-of-leprosy-a-study-based-on-geo-datasets
#4
JOURNAL ARTICLE
Qun Zhou, Ping Shi, Wei Dong Shi, Jun Gao, Yi Chen Wu, Jing Wan, Li Li Yan, Yi Zheng
Leprosy has a high rate of cripplehood and lacks available early effective diagnosis methods for prevention and treatment, thus novel effective molecule markers are urgently required. In this study, we conducted bioinformatics analysis with leprosy and normal samples acquired from the GEO database(GSE84893, GSE74481, GSE17763, GSE16844 and GSE443). Through WGCNA analysis, 85 hub genes were screened(GS > 0.7 and MM > 0.8). Through DEG analysis, 82 up-regulated and 3 down-regulated genes were screened(|Log2FC| > 3 and FDR < 0...
2024: PloS One
https://read.qxmd.com/read/38739593/cyb561-supports-the-neuroendocrine-phenotype-in-castration-resistant-prostate-cancer
#5
JOURNAL ARTICLE
Romie Angelo G Azur, Kevin Christian V Olarte, Weand S Ybañez, Alessandria Maeve M Ocampo, Pia D Bagamasbad
Castration-resistant prostate cancer (CRPC) is associated with resistance to androgen deprivation therapy, and an increase in the population of neuroendocrine (NE) differentiated cells. It is hypothesized that NE differentiated cells secrete neuropeptides that support androgen-independent tumor growth and induce aggressiveness of adjacent proliferating tumor cells through a paracrine mechanism. The cytochrome b561 (CYB561) gene, which codes for a secretory vesicle transmembrane protein, is constitutively expressed in NE cells and highly expressed in CRPC...
2024: PloS One
https://read.qxmd.com/read/38739464/detection-of-genetic-mutations-underlying-early-onset-systemic-lupus-erythematosus
#6
JOURNAL ARTICLE
Seher Sener, Erdal Sag, Xu Han, Yelda Bilginer, Qing Zhou, Seza Ozen
OBJECTIVE: We aimed to investigate the presence of monogenic causes of systemic lupus erythematosus (SLE) in our early-onset SLE patients. METHODS: Fifteen pediatric SLE cases who had early disease onset (≤6 years) were enrolled in this study. All patients fulfilled the Systemic Lupus International Collaborating Clinics (SLICC) criteria. Genomic DNA was used for whole exome sequencing (WES). Pathogenic variants were confirmed by Sanger sequencing. RESULTS: The median age at diagnosis of 15 early-onset SLE patients included in the study was 4 (2-6) years (F/M = 12/3)...
May 13, 2024: Lupus
https://read.qxmd.com/read/38739347/malignant-perineurioma-derived-from-the-retroperitoneum-with-an-aggressive-clinical-course-a-case-report
#7
JOURNAL ARTICLE
Ken Kunugitani, Satoshi Ogiso, Masakazu Fujimoto, Tomoaki Yoh, Hisaya Shirai, Shinya Okumura, Hirofumi Hirao, Takamichi Ishii, Akihiko Yoshida, Etsuro Hatano
BACKGROUND: Malignant perineurioma is a rare malignant counterpart of perineurioma derived from perineural cells. Resection is the primary option for the treatment of malignant perineuriomas; however, patients often develop recurrence after resection, and effective treatment for advanced or recurrent lesions needs to be established. This report describes a 51-year-old female with a rare malignant perineurioma in the retroperitoneum, which contributing valuable insights to the literature...
May 13, 2024: Surgical Case Reports
https://read.qxmd.com/read/38739187/precision-oncology-in-neurofibromatosis-type-1-quantification-of-differential-sensitivity-to-selumetinib-in-plexiform-neurofibromas-using-single-cell-rna-sequencing
#8
JOURNAL ARTICLE
Archis R Bhandarkar, Shaan Bhandarkar, Dusica Babovic-Vuksanovic, Aditya Raghunathan, Jonathan Schwartz, Robert J Spinner
PURPOSE: Selumetinib is an FDA-approved targeted therapy for plexiform neurofibromas in neurofibromatosis type 1(NF1) with durable response rates seen in most, but not all patients. In this proof-of-concept study, we demonstrate single-cell RNA sequencing(scRNAseq) as a technique for quantifying drug response to selumetinib at the single cell level. METHODS: scRNAseq data from neurofibroma biopsies was obtained from a public genomics repository. Schwann cell populations were identified through standard clustering techniques and single-cell selumetinib sensitivity was quantified on a scale of 0(resistant) to 1(sensitive) based on the expression pattern of a 500 gene selumetinib sensitivity signature from the BeyondCell sensitivity library...
May 13, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38738802/the-effects-of-convalescent-plasma-transfusion-on-serum-levels-of-macrophage-associated-inflammatory-biomarkers-in-patients-with-severe-covid-19
#9
JOURNAL ARTICLE
Mojtaba Shohan, Mohammad Reza Mahmoudian-Sani, Ali Saeedi-Boroujeni, Sara Iranparast, Roohangiz Nashibi, Farhad Abolnezhadian, Farid Yousefi, Seyed Mohammad Alavi, Bahman Cheraghian, Ali Khodadadi
As an antibody-based therapy, plasma therapy has been used as an emergency therapeutic strategy against severe acute respiratory syndrome coronavirus type 2 infection. Due to the critical role of macrophages in coronavirus disease-19 (COVID-19)-associated hyperinflammation, the main objective of this study was to assess the effect of plasma transfusion on the expression levels of the inflammatory biomarkers involved in activation and pulmonary infiltration of macrophages. The target population included 50 severe hospitalized COVID-19 patients who were randomly assigned into 2 groups, including intervention and control...
May 13, 2024: Journal of Interferon & Cytokine Research
https://read.qxmd.com/read/38738796/an-ovine-model-yields-histology-and-gene-expression-changes-consistent-with-laryngotracheal-stenosis
#10
JOURNAL ARTICLE
Laura Mafla, Raymond J So, Samuel L Collins, Yee Chan-Li, Ioan Lina, Kevin M Motz, Alexander T Hillel
OBJECTIVES: Animal models for laryngotracheal stenosis (LTS) are critical to understand underlying mechanisms and study new therapies. Current animal models for LTS are limited by small airway sizes compared to human. The objective of this study was to develop and validate a novel, large animal ovine model for LTS. METHODS: Sheep underwent either bleomycin-coated polypropylene brush injury to the subglottis (n = 6) or airway stent placement (n = 2) via suspension microlaryngoscopy...
May 13, 2024: Laryngoscope
https://read.qxmd.com/read/38738772/based-on-immune-microenvironment-and-genomic-status-exploring-immunotherapy-in-advanced-hidradenocarcinoma-a-retrospective-analysis
#11
JOURNAL ARTICLE
Jing Lin, Li Zhu, Yanping Chen, Qian Li, Zhiheng Ke, Huishan Zhang, Yufang Huang, Jianping Lu, Yu Chen
There are no standard treatment guidelines for hidradenocarcinoma, and the immune microenvironment and genomic data are very limited. Thus, in this study the immune microenvironment and genomic indicators in hidradenocarcinoma was investigated, and immunotherapy for hidradenocarcinoma was initially explored. Forty-seven hidradenocarcinoma patients were retrospectively collected. Immunohistochemical staining was performed to identify CD3/CD8+ T cells and programmed death ligand-1 expression. In total, 89.4% and 10...
May 13, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38738727/advancements-in-crispr-based-therapies-for-genetic-modulation-in-neurodegenerative-disorders
#12
JOURNAL ARTICLE
Bharat Bhushan, Kuldeep Singh, Shivendra Kumar, Anjali Bhardwaj
: Neurodegenerative disorders pose significant challenges in the realm of healthcare, as these conditions manifest in complex, multifaceted ways, often attributed to genetic anomalies. With the emergence of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology, a new frontier has been unveiled in the quest for targeted, precise genetic manipulation. This abstract explores the recent advancements and potential applications of CRISPR-based therapies in addressing genetic components contributing to various neurodegenerative disorders...
May 10, 2024: Current Gene Therapy
https://read.qxmd.com/read/38738582/noncanonical-functions-of-telomerase-and-telomeres-in-viruses-associated-cancer
#13
REVIEW
Sara Rasouli, Aleksandra Dakic, Qi-En Wang, Darrion Mitchell, Dukagjin M Blakaj, Nagireddy Putluri, Jenny Li, Xuefeng Liu
The cause of cancer is attributed to the uncontrolled growth and proliferation of cells resulting from genetic changes and alterations in cell behavior, a phenomenon known as epigenetics. Telomeres, protective caps on the ends of chromosomes, regulate both cellular aging and cancer formation. In most cancers, telomerase is upregulated, with the telomerase reverse transcriptase (TERT) enzyme and telomerase RNA component (TERC) RNA element contributing to the maintenance of telomere length. Additionally, it is noteworthy that two viruses, human papillomavirus (HPV) and Epstein-Barr virus (EBV), utilize telomerase for their replication or persistence in infected cells...
May 2024: Journal of Medical Virology
https://read.qxmd.com/read/38738555/mettl14-decreases-fth1-mrna-stability-via-m6a-methylation-to-promote-sorafenib-induced-ferroptosis-of-cervical-cancer
#14
JOURNAL ARTICLE
Lijie Li, Jie Zeng, Sili He, Yanfei Yang, Chen Wang
Cervical cancer (CC) is a prevalent malignancy among women worldwide. This study was designed to investigate the role of METTL14 in sorafenib-induced ferroptosis in CC. METTL14 expression and m6A methylation were determined in CC tissues, followed by analyzes correlating these factors with clinical features. Subsequently, METTL14 was knocked down in CC cell lines, and the effects on cell proliferation, mitochondrial morphology and ferroptosis were assessed using CCK-8, microscopy, and markers associated with ferroptosis, respectively...
December 31, 2024: Cancer Biology & Therapy
https://read.qxmd.com/read/38738539/prognostic-biomarkers-in-melanoma-a-2023-update-from-clinical-trials-in-different-therapeutic-scenarios
#15
REVIEW
Gabriele Roccuzzo, Cristina Sarda, Valentina Pala, Simone Ribero, Pietro Quaglino
INTRODUCTION: Over the past decade, significant advancements in the field of melanoma have included the introduction of a new staging system and the development of immunotherapy and targeted therapies, leading to changes in substage classification and impacting patient prognosis. Despite these strides, early detection remains paramount. The quest for dependable prognostic biomarkers is ongoing, given melanoma's unpredictable nature, especially in identifying patients at risk of relapse...
May 13, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38738427/perspectives-on-the-currently-available-pharmacotherapy-for-wet-macular-degeneration
#16
REVIEW
Aneeta Kumar, Lorenzo Ferro Desideri, Magdalene Yin Lin Ting, Rodrigo Anguita
INTRODUCTION: Wet age-related macular degeneration (w-AMD) is a leading cause of visual impairment globally, with its prevalence expected to rise alongside increasing life expectancy. The current standard treatment involves frequent intravitreal injections of anti-VEGF agents, which although revolutionary, pose significant burdens on both patients and healthcare services. AREAS COVERED: This review explores current and emerging pharmaceutical treatments for w-AMD, focusing on their pharmacokinetics, pharmacodynamics, efficacy, and safety...
May 13, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38738394/the-current-status-of-various-preclinical-therapeutic-approaches-for-tendon-repair
#17
REVIEW
Wenqing Liang, Chao Zhou, Yongjun Deng, Lifeng Fu, Jiayi Zhao, Hengguo Long, Wenyi Ming, Jinxiang Shang, Bin Zeng
Tendons are fibroblastic structures that link muscle and bone. There are two kinds of tendon injuries, including acute and chronic. Each form of injury or deterioration can result in significant pain and loss of tendon function. The recovery of tendon damage is a complex and time-consuming recovery process. Depending on the anatomical location of the tendon tissue, the clinical outcomes are not the same. The healing of the wound process is divided into three stages that overlap: inflammation, proliferation, and tissue remodeling...
December 2024: Annals of Medicine
https://read.qxmd.com/read/38738344/electrical-signature-of-heterogeneous-human-mesenchymal-stem-cells
#18
JOURNAL ARTICLE
Tunglin Tsai, Prema D Vyas, Lexi L Crowell, Mary Tran, Destiney W Ward, Yufan Qin, Angie Castro, Tayloria N G Adams
Human mesenchymal stem cells (hMSCs) have gained traction in transplantation therapy due to their immunomodulatory, paracrine, immune-evasive, and multipotent differentiation potential. The inherent heterogeneity of hMSCs poses a challenge for therapeutic treatments and necessitates the identification of robust biomarkers to ensure reproducibility in both in vivo and in vitro experiments. In this study, we utilized dielectrophoresis (DEP), a label-free electrokinetic phenomenon, to investigate the heterogeneity of hMSCs derived from bone marrow (BM) and adipose tissue (AD)...
May 13, 2024: Electrophoresis
https://read.qxmd.com/read/38738189/clinical-utility-of-blood-culture-identification-2-panel-in-flagged-blood-culture-samples-from-the-intensive-care-unit-of-a-tertiary-care-hospital
#19
JOURNAL ARTICLE
Vashemane K Vineeth, Panchatcharam S Nambi, Ram Gopalakrishnan, Nandini Sethuraman, Yamunadevi Ramanathan, Chitra Chandran, Venkatasubramanian Ramasubramanian
BACKGROUND: The availability of rapid diagnostic platforms for positive blood cultures has accelerated the speed at which the clinical microbiology laboratory can identify the causative organism and facilitate early appropriate antimicrobial therapy. There is a paucity of data regarding the clinical utility of the blood culture identification 2 (BCID2) panel test and its correlation with phenotypic drug susceptibility testing (DST) in flagged blood culture bottles from intensive care units (ICUs) in countries such as India, which have high rates of multidrug-resistant gram-negative bacteria (MDR-GNB)...
May 2024: Indian Journal of Critical Care Medicine
https://read.qxmd.com/read/38738088/current-concepts-in-the-management-of-sanfilippo-syndrome-mps-iii-a-narrative-review
#20
REVIEW
Anas S Alyazidi, Osama Y Muthaffar, Layan S Baaishrah, Mohammed K Shawli, Abdulaziz T Jambi, Maram A Aljezani, Majdah A Almaghrabi
Sanfilippo syndrome is a childhood-onset (1-4 years) autosomal recessive lysosomal storage disease that presents as a neurodegenerative disease by targeting the brain and spinal cord. It is also known as mucopolysaccharidosis III. Mucopolysaccharidosis III is divided into four subtypes (A, B, C, or D). It can cause delayed speech, behavior problems, and features of autism spectrum disorder. Sanfilippo syndrome is of a higher prevalence within consanguineous families that carry its gene alteration. If both parents have a nonfunctional copy of a gene linked to this condition, their children will have a 25% (1 in 4) chance of developing the disease...
April 2024: Curēus
keyword
keyword
3703
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.